Colorectal Cancer News and reporting on colorectal cancer. Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE Dante labs will market the test in Italy and the UAE, with Mainz initially processing samples in its lab and Dante later adopting IVD kits for in-house use. Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism Premium Having officially launched its Shield colorectal cancer screening assay as an LDT, Guardant stands to benefit from a head start in clinical establishment. As Competing Blood-Based Cancer Screening Tests Loom, Exact Sciences Stresses Cologuard Advantage Premium With the field awaiting new data from its competitor Guardant Health this year, Exact argued for skepticism on the future of blood-based CRC screening. Exact Sciences Q1 Revenues up 21 Percent The firm reported total revenues of $486.6 million, driven by growth for both screening and precision oncology products as COVID-19 testing continues to wane. Clinical Polygenic Risk Assay, Reporting Pipeline Shows Promise for Multiple Conditions Premium Researchers developed assays to assess PRSs for six common conditions, along with methods for sharing the results with doctors and patients. Mar 30, 2022 Genetron Health Adds New Assays to Pipeline While Anticipating MRD Launch, Liver Cancer Kit Trials Premium Mar 23, 2022 Burning Rock Adds Validation Data as it Begins MRD and Early Detection Commercialization Premium Feb 17, 2022 Mainz Biomed Developing New Version of ColoAlert Assay Ahead of FDA Submission Premium Feb 14, 2022 Mainz Biomed Partners with German Regional Lab on Colorectal Cancer Test Commercialization Feb 10, 2022 Genetic Cancer Risk Varies by Ancestry in Qatari Population, New Analysis Finds Feb 4, 2022 Combining Environmental, Polygenic Risk Factors May Improve Colorectal Cancer Screening Premium Jan 26, 2022 Early Detection, MRD Test Data Get Optimistic Reception From GI Oncologists at ASCO Meeting Premium Jan 26, 2022 Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering Jan 19, 2022 Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Jan 5, 2022 Mainz Biomed Licenses mRNA Biomarkers for Colorectal Cancer Dec 14, 2021 Mainz Biomed, Ganzimmun Diagnostics Partner to Commercialize Colorectal Cancer Test Dec 7, 2021 Freenome Raises $300M in Series D Financing Dec 6, 2021 Redx Pharma, Caris Life Sciences Partner for Colorectal Cancer Phase II Drug Study Recruitment Nov 24, 2021 HER2 Treatments See New Milestones in Colorectal Cancer, With Liquid Biopsy Identifying Responders Premium Nov 16, 2021 Cancer Genomic Analysis Reveals Distinct Features in Tumors From Patients Under 50 Years Old Nov 16, 2021 Geneoscopy Closes $105M Series B Financing Round Nov 8, 2021 German MDx Firm Mainz Biomed Raises $10M in IPO, Begins Trading on Nasdaq Nov 5, 2021 Natera Aiming to Translate Success in Colorectal Cancer Diagnostics Into Other Areas Premium Nov 3, 2021 Exact Sciences Gearing up for Busy 2022, Beyond Premium Oct 27, 2021 Joint Venture From SEngine, Gustave Roussy Aims to Commercialize Cancer Dx Test Across Europe Premium Load More Breaking News Single-Nucleus Chromatin Accessibility Profiling in Coronary Artery Disease Points to Mechanisms ALL Genomes Marked by High DNA Methylation Levels Cepheid Gets CE Mark for Updated Rapid COVID MDx Test Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE CellCarta Acquires Rights to Targeted Protein Assays from Fred Hutch Spinout Precision Assays Genetic Analysis, Omnigene Medical Technologies Ink Distribution, Tech Transfer Deal The Scan Monkeypox Case Found in US The New York Times says that a case of monkeypox has now been reported in the US. Effects on Fetal Screening Wired writes that changes to US abortion laws could affect screening for fatal congenital conditions. 'Pharma Bro' Out of Prison The Wall Street Journal reports that Martin Shkreli has been released from prison to a halfway house. Nature Papers Present Cultivate Oat Genome, Benchmarking of Spatial and Single-Cell Transcriptomic Integration Methods In Nature this week: reference genome of the cultivated oat, and more.